Search Results - fu-shin yu

3 Results

Sort By:

Topical treatment with TGFbeta3 to facilitate skin and corneal wound healing in diabetic patients

Topical Treatment with TGFb3 to Facilitate Skin and Corneal Wound Healing in Diabetic Patients WSU Tech#: 14-1207 Technology Summary: TGFb3 has been implicated in the reduction of scar formation in wound healing. Renovo Group PLC, is a European based biopharmaceutical company developing drugs to reduce scaring, improve wound healing and enhance...

Published: 2/10/2017 | Inventor(s): Fu-Shin Yu

Keywords(s):

Category(s): Medical, Biologicals, Biomedical, Drug Discovery, Metabolic disorders, Protein/peptides, Therapeutics, Life Science

Topical IL-1Ra (anakinra) in the form of gel to treat persistent diabetic skin and corneal wounds

BackgroundAnakinra (aka. Kineret) is a recombinant human IL-1Ra that was developed by Amgen. It is currently used to treat moderately to severely active rheumatoid arthritis, but also treats neonatal-onset multisystem inflammatory disease (NOMID). Anakinra is given as an IV dose and the drug is no longer under patent. The properties of Anakinra a...

Published: 5/25/2016 | Inventor(s): Fu-Shin Yu

Keywords(s):

Category(s): Biologicals, Drug Discovery, Pharmaceuticals, Therapeutics

Using Flagellin to Prevent and to Treat Inflammation Associated Gram Negative Bacterial Infection

This technology provides a new method for treating inflammatory diseases by using a Gram negative bacterial component that results in increased tolerance and immunity. Background & Unmet Need: Despite advances of modern medicine, bacterial sepsis remains one of the major threats to human health worldwide. In the US alone, it affects approxima...

Published: 5/18/2010 | Inventor(s): Fu-Shin Yu, Ashok Kumar, Jing Zhang, Linda Hazlett

Keywords(s): Anti-microbial, Asthma

Category(s): Therapeutics, Diseases, Life Science, Infectious disease